Line 5: | Line 5: | ||
<div class="container"> | <div class="container"> | ||
<div id="title" style="background-image: url(https://static.igem.org/mediawiki/2017/0/0c/T--Bielefeld-CeBiTec--title-img-analyzing.jpg);"> | <div id="title" style="background-image: url(https://static.igem.org/mediawiki/2017/0/0c/T--Bielefeld-CeBiTec--title-img-analyzing.jpg);"> | ||
− | <img src=" | + | <img src=""> |
<div id="title-bg"> | <div id="title-bg"> | ||
<div id="title-text"> | <div id="title-text"> | ||
Line 38: | Line 38: | ||
</article> | </article> | ||
− | <div class="figure | + | <div class="figure large"> |
<img class="figure image" src="https://static.igem.org/mediawiki/2017/a/a2/T--Bielefeld-CeBiTec--SVI-Analysing-results-1.png"> | <img class="figure image" src="https://static.igem.org/mediawiki/2017/a/a2/T--Bielefeld-CeBiTec--SVI-Analysing-results-1.png"> | ||
<p class="figure subtitle"><b>Figure 1:</b>Alignment of the amino acid sequence of PrK-aaRS and the wildtype <i>methanosarzia mazei</i> Pyl-RS.</p> | <p class="figure subtitle"><b>Figure 1:</b>Alignment of the amino acid sequence of PrK-aaRS and the wildtype <i>methanosarzia mazei</i> Pyl-RS.</p> | ||
</div> | </div> | ||
+ | <article> | ||
+ | The alignment of the wildtype PylRS from <i>methanosarzia mazei</i> and the evolved synthetase for the incorporations of PrK shows only one amino acid exchange at position 124. Although this is the aaRS with the least amino acid exchanges of our toolkit, it turned out to be the most specific. We proved the incorporation of PrK through this synthetase with our screening system for the incorporation of ncAAs. The results from our screening system, which compares the incorporation efficiency and specify are shown in figure 2. For more details of our screening method, please refer to the part improvement page. | ||
+ | </article> | ||
+ | <div class="figure medium"> | ||
+ | <img class="figure image" src="https://static.igem.org/mediawiki/2017/f/fc/T--Bielefeld-CeBiTec--SVI-Analysing-results-2.png"> | ||
+ | <p class="figure subtitle"><b>Figure 2:</b> Comparison of the incorporation rate of PrK and native amino acids through the evolved PrK-aaRS.</p> | ||
+ | </div> | ||
+ | <div class="figure large"> | ||
+ | <img class="figure image" src="https://static.igem.org/mediawiki/2017/2/27/T--Bielefeld-CeBiTec--SVI-Analysing-results-3.png"> | ||
+ | <p class="figure subtitle"><b>Figure 3:</b> Alignment of the amino acid sequence of the evolved AcF-aaRS and the wildtype TyrRS from <i>methancoccus jannaschii</i>.</p> | ||
+ | </div> | ||
− | + | <article> | |
+ | Because of the recommendation of our expert Iker Valle Aramburu, we decided to use only one ncAA to label our test protein and label the second fluorophore through maleimide labeling to a cysteine. This labeling strategy could only be used for proteins that are cysteine free or in which all cysteines could be replaced. Because this is only possible in a few applications we decided to provide a second evolved aaRS for the incorporation of AcF in response to the less used leucine codon CUA. The sequence of the synthetase is similar to the aaRS described by Kim 2012 to incorporate AcF in response to CUA . | ||
+ | </article> | ||
</div> | </div> | ||
<div class="bevel bl"></div> | <div class="bevel bl"></div> | ||
</div> | </div> | ||
+ | |||
+ | |||
+ | |||
Revision as of 17:12, 29 October 2017
Analyzing
Short summary
Evolved synthetases for the incorporation of propargyllysine and p-acetophenylalanine
We received plasmids from the Lemke group from EMBL in Heidelberg containing an evolved tyrosyl tRNA/ synthtase pair (tRNA/TyrRS) from Methanococcus jannaschii for the incorporation of AcF and an evolved pyrrolysyl synthetase from Methanosarcina mazei for the incorporation of PrK, both in response to the amber codon. We used Gibson assembly to clone the tRNA/aaRS and the tRNA from these plasmids into pSB1C3 and replaced cutting sites for EcoRI and SpeI with site directed mutagenesis to provide these synthetases for the iGEM community. Furthermore, we changed the anticodon in the tRNA of the TyrRS tRNA to the anticodon for the less used leucine codon, so the new aaRS incorporates AcF in response to the codon CTA. An alignment of both evolved synthetases with the wildtypes are shown in figure 1 (PrK-aaRS) and 3(AcF-aaRS).
Figure 1:Alignment of the amino acid sequence of PrK-aaRS and the wildtype methanosarzia mazei Pyl-RS.
Figure 2: Comparison of the incorporation rate of PrK and native amino acids through the evolved PrK-aaRS.
Figure 3: Alignment of the amino acid sequence of the evolved AcF-aaRS and the wildtype TyrRS from methancoccus jannaschii.
Construction of the expression plasmid for the Sup35 test protein
According to our expert Iker Valle Aramburu, the incorporation of two noncanonical amino acids lowers the yield. He recommended us to use only one noncanonical amino acid and one cysteine, which could be labeled in a maleimide coupling reaction. Mukhopadhyay 2006 showed that mutants of Sup35 containing no cysteines are still able to form prions. So we decided to order a gene synthesis of sup35 containing no cysteines.
For our experiments we cloned the gene synthesis of the NM region of Sup35 into pSB1C3 and used site directed mutagenizes to construct the part BBa_K2201231 containing a histag, one amber codon at position 21 and a cysteine codon at position 121. The control BBa_K2201232 contains cysteine codons at positions 21 and 121. In addition, we constructed these three parts also with a T7-promotor and RBS (BBa_K2201331 and BBa_K2201332), for the inducible expression of the Sup35 variants.